Home › Major Depressive Disorder › Arizona › Phoenix
Major Depressive Disorder clinical trials in Phoenix, AZ
7 studies for Major Depressive Disorder are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 2
- IMA Clinical Research- Phoenix, Phoenix
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
RecruitingPhase 3
- Vanda Investigational Site, Phoenix
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
RecruitingPhase 2
- Draig Clinical Site, Phoenix
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
RecruitingPhase 3
- IMA Clinical Research Phoenix, Phoenix
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
RecruitingPhase 2
- NoesisPharma, LLC, Phoenix
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
RecruitingPhase 2
- Ima Clinical Research Phoenix (Alea) /ID# 277516, Phoenix
Study of ALTO-300 in MDD
RecruitingPhase 2
- Site 200, Phoenix
Major Depressive Disorder trials in other cities
- New York City, NY37 studies
- Boston, MA30 studies
- Atlanta, GA24 studies
- Philadelphia, PA22 studies
- Orlando, FL19 studies
- Tampa, FL17 studies
- Miami, FL17 studies
- Chicago, IL16 studies
- Houston, TX16 studies
- San Diego, CA16 studies
- Little Rock, AR14 studies
- Austin, TX13 studies
Other studies in Phoenix
- Colorectal Cancer25 studies
- Breast Cancer25 studies
- Obesity23 studies
- Metastatic Cancer20 studies
- Non-Small Cell Lung Cancer20 studies
- Heart Failure18 studies
- Pancreatic Cancer17 studies
- Cancer (all types)17 studies
- Prostate Cancer17 studies
- Multiple Myeloma16 studies
- Cardiovascular Disease16 studies
- Alzheimer's Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.